CVS
CVS Health Corporation
$89.35−0.44 (−0.49%)Close Nov 13, 2026
Insider trading
12 months to Nov 6, 2026- Net sold
- $322M
- Sales less buys
- Bought
- $2.00M
- Prem S. Shah
- Sold
- $324M
- 2 insiders
- Latest buy
- Nov 6, 2026
- Prem S. Shah
Buys and sales on the price
Since 2003By period
Open-market trades| Trades | 3 months | 12 months | Since 2003 |
|---|---|---|---|
| Buys | 1 | 1 | 44 |
| Sales | 0 | 4 | 293 |
| Plan sales | 0 | 0 | 176 |
| Shares bought | 23,85523.9K | 23,85523.9K | 484,094484K |
| Shares sold | 00 | 3,441,5513.44M | 33,938,44633.9M |
| Net shares | +23,855+23.9K | −3,417,696−3.42M | −33,454,352−33.5M |
| Net value | +$2.00M | −$322M | −$1.81B |
Insiders
| Insider | 12 months | Shares held |
|---|---|---|
Larry Robbins Director | −41.1% | 4,824,799 |
C. David Brown II Director | — | 129,316 |
Prem S. Shah EVP and Group President | +39.3% | 88,516 |
J. David Joyner President, CEO and Chair, Director | — | 70,349 as of Apr 2, 2026 |
Anne A. Finucane Director | — | 47,945 |
Trades
337 trades since 2003| Type | Insider | Role | Shares | Price | Held after | |||
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Buy | Prem S. ShahEVP and Group President EVP and Group President | EVP and Group President | 23,855 at $83.90 | $83.90 | $2.00M | +36.9% 88.5K after | 88,516 |
| May 21, 2026 | Sale | Larry RobbinsDirector Director | Director | 370,462 at $93.45 | $93.45 | $34.6M | −7.1% 4.82M after | 4,824,799 |
| May 20, 2026 | Sale | Larry RobbinsDirector Director | Director | 1,018,000 at $93.82 | $93.82 | $95.5M | −16.4% 5.20M after | 5,195,261 |
| May 19, 2026 | Sale | Larry RobbinsDirector Director | Director | 1,983,538 at $94.45 | $94.45 | $187M | −24.2% 6.21M after | 6,213,261 |
| May 8, 2026 | Sale | Tilak MandadiEVP, Chief Exp & Tech Officer EVP, Chief Exp & Tech Officer | EVP, Chief Exp & Tech Officer | 69,551 at $89.58 | $89.58 | $6.23M | −87.3% 10.1K after | 10,133 |
| Aug 20, 2025 | Sale | Anne A. FinucaneDirector Director | Director | 7,500 at $71.02 | $71.02 | $533K | −13.5% 48.0K after | 48,046 |
| Jun 5, 2025 | Buy | Guy P. SansoneDirector Director | Director | 1,570 at $63.70 | $63.70 | $100K | +15.0% 12.0K after | 12,007 |
| May 6, 2025 | Sale | Larry RobbinsDirector Director | Director | 150,000 at $66.67 | $66.67 | $10.0M | −1.8% 8.20M after | 8,196,799 |
| May 5, 2025 | Sale | Larry RobbinsDirector Director | Director | 1,323,932 at $67.41 | $67.41 | $89.2M | −13.7% 8.35M after | 8,346,799 |
| May 2, 2025 | Sale | Larry RobbinsDirector Director | Director | 2,276,068 at $67.86 | $67.86 | $154M | −19.1% 9.67M after | 9,670,731 |
- Prem S. Shah$2.00MNov 6, 2026 · Buy23,855 at $83.90EVP and Group President+36.9% of holdings, 88.5K after
- Larry Robbins$34.6MMay 21, 2026 · Sale370,462 at $93.45Director−7.1% of holdings, 4.82M after
- Larry Robbins$95.5MMay 20, 2026 · Sale1,018,000 at $93.82Director−16.4% of holdings, 5.20M after
- Larry Robbins$187MMay 19, 2026 · Sale1,983,538 at $94.45Director−24.2% of holdings, 6.21M after
- Tilak Mandadi$6.23MMay 8, 2026 · Sale69,551 at $89.58EVP, Chief Exp & Tech Officer−87.3% of holdings, 10.1K after
- Anne A. Finucane$533KAug 20, 2025 · Sale7,500 at $71.02Director−13.5% of holdings, 48.0K after
- Guy P. Sansone$100KJun 5, 2025 · Buy1,570 at $63.70Director+15.0% of holdings, 12.0K after
- Larry Robbins$10.0MMay 6, 2025 · Sale150,000 at $66.67Director−1.8% of holdings, 8.20M after
- Larry Robbins$89.2MMay 5, 2025 · Sale1,323,932 at $67.41Director−13.7% of holdings, 8.35M after
- Larry Robbins$154MMay 2, 2025 · Sale2,276,068 at $67.86Director−19.1% of holdings, 9.67M after